| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $2.44 (Beat by $0.15) |
| EPS GAAP Actual | $2.44 (Beat by $0.15) |
| Revenue Actual | $4.749B |
| Revenue Surprise | Beat by $4749M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 12.075 | 20.17 | 11.34349 | 13.44529 | 3 |
| Sep 2028 | 10.3 | 23.65 | 10.10181 | 10.74823 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.25 | 2.25 | 4.749B | 14.34% | 4749M |
| FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 4.534B | 12.24% | 4534M |
| FQ1 2025 (Mar 2025) | 6.19 | 6.19 | 4.143B | 4.25% | 4143M |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 3.836B | 0.13% | 3836M |
| FQ3 2024 (Sep 2024) | 3.43 | 3.43 | 4.068B | 0.81% | 4068M |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 3.979B | -0.48% | 3979M |
| FQ1 2024 (Mar 2024) | 1.76 | 1.76 | 3.967B | 100% | 3967M |
| FQ4 2023 (Dec 2023) | 5.8 | 5.8 | 3.831B | -0.26% | 3831M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 2.59758 | -- | 2.5721 | 2.66437 | 9 |
| FQ2 2027 (Jun 2027) | 2.54206 | -- | 2.51712 | 2.60742 | 9 |
| FQ1 2027 (Mar 2027) | 2.37268 | -- | 2.3494 | 2.43368 | 9 |
| FQ4 2026 (Dec 2026) | 2.30591 | -- | 2.24564 | 2.36081 | 6 |
| FQ3 2026 (Sep 2026) | 2.36583 | 4.9 | 2.34262 | 2.42666 | 5 |
| FQ2 2026 (Jun 2026) | 2.27034 | 4.86 | 2.24807 | 2.32871 | 5 |
| FQ1 2026 (Mar 2026) | 2.3 | -169.13 | 2.2608 | 2.35486 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 4.91B | -- | 4.87B | 5.01B | 6 |
| FQ2 2027 (Jun 2027) | 4.77B | -- | 4.74B | 4.87B | 6 |
| FQ1 2027 (Mar 2027) | 4.59B | -- | 4.56B | 4.69B | 6 |
| FQ4 2026 (Dec 2026) | 4.45B | -- | 4.36B | 4.53B | 8 |
| FQ3 2026 (Sep 2026) | 4.56B | -4.24 | 4.52B | 4.65B | 6 |
| FQ2 2026 (Jun 2026) | 4.42B | -2.57 | 4.39B | 4.51B | 6 |
| FQ1 2026 (Mar 2026) | 4.52B | 8.42 | 4.46B | 4.61B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.25 | 2.25 | 100% | |
| FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 100% | |
| FQ1 2025 (Mar 2025) | 6.19 | 6.19 | 100% | |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 100% | |
| FQ3 2024 (Sep 2024) | 3.43 | 3.43 | 100% | |
| FQ2 2024 (Jun 2024) | 1.87 | 1.87 | 100% | |
| FQ1 2024 (Mar 2024) | 1.76 | 1.76 | 100% | |
| FQ4 2023 (Dec 2023) | 5.8 | 5.8 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $4.75B | $4749M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $4.53B | $4534M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $4.14B | $4143M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.84B | $3836M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.07B | $4068M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.98B | $3979M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.97B | $3967M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.83B | $3831M | 100% |